Literature DB >> 32405162

A study on infectivity of asymptomatic SARS-CoV-2 carriers.

Ming Gao1, Lihui Yang2, Xuefu Chen3, Yiyu Deng4, Shifang Yang5, Hanyi Xu6, Zixing Chen7, Xinglin Gao8.   

Abstract

BACKGROUND: An ongoing outbreak of coronavirus disease 2019 (COVID-19) has spread around the world. It is debatable whether asymptomatic COVID-19 virus carriers are contagious. We report here a case of the asymptomatic patient and present clinical characteristics of 455 contacts, which aims to study the infectivity of asymptomatic carriers.
MATERIAL AND METHODS: 455 contacts who were exposed to the asymptomatic COVID-19 virus carrier became the subjects of our research. They were divided into three groups: 35 patients, 196 family members and 224 hospital staffs. We extracted their epidemiological information, clinical records, auxiliary examination results and therapeutic schedules.
RESULTS: The median contact time for patients was four days and that for family members was five days. Cardiovascular disease accounted for 25% among original diseases of patients. Apart from hospital staffs, both patients and family members were isolated medically. During the quarantine, seven patients plus one family member appeared new respiratory symptoms, where fever was the most common one. The blood counts in most contacts were within a normal range. All CT images showed no sign of COVID-19 infection. No severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections was detected in 455 contacts by nucleic acid test.
CONCLUSION: In summary, all the 455 contacts were excluded from SARS-CoV-2 infection and we conclude that the infectivity of some asymptomatic SARS-CoV-2 carriers might be weak.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Keywords:  Asymptomatic carrier; Contacts; Infectivity; SARS-CoV-2

Year:  2020        PMID: 32405162      PMCID: PMC7219423          DOI: 10.1016/j.rmed.2020.106026

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  12 in total

1.  Clinical Characteristics of Covid-19 in China. Reply.

Authors:  Wei-Jie Guan; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

2.  COVID-19-New Insights on a Rapidly Changing Epidemic.

Authors:  Carlos Del Rio; Preeti N Malani
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

3.  Priorities for the US Health Community Responding to COVID-19.

Authors:  Amesh A Adalja; Eric Toner; Thomas V Inglesby
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

4.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.

Authors:  Sana Salehi; Aidin Abedi; Sudheer Balakrishnan; Ali Gholamrezanezhad
Journal:  AJR Am J Roentgenol       Date:  2020-03-14       Impact factor: 3.959

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.

Authors:  Lirong Zou; Feng Ruan; Mingxing Huang; Lijun Liang; Huitao Huang; Zhongsi Hong; Jianxiang Yu; Min Kang; Yingchao Song; Jinyu Xia; Qianfang Guo; Tie Song; Jianfeng He; Hui-Ling Yen; Malik Peiris; Jie Wu
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

8.  Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.

Authors:  Zhiliang Hu; Ci Song; Chuanjun Xu; Guangfu Jin; Yaling Chen; Xin Xu; Hongxia Ma; Wei Chen; Yuan Lin; Yishan Zheng; Jianming Wang; Zhibin Hu; Yongxiang Yi; Hongbing Shen
Journal:  Sci China Life Sci       Date:  2020-03-04       Impact factor: 10.372

9.  Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma.

Authors:  Brian McCloskey; Alimuddin Zumla; Giuseppe Ippolito; Lucille Blumberg; Paul Arbon; Anita Cicero; Tina Endericks; Poh Lian Lim; Maya Borodina
Journal:  Lancet       Date:  2020-03-20       Impact factor: 79.321

Review 10.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.

Authors:  Yixuan Wang; Yuyi Wang; Yan Chen; Qingsong Qin
Journal:  J Med Virol       Date:  2020-03-29       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.